ABBVIE FDA Approval NDA 021606

NDA 021606

ABBVIE

FDA Drug Application

Application #021606

Documents

Letter2009-07-07
Letter2010-06-15
Letter2011-04-19
Letter2011-04-11
Letter2014-09-03
Label2005-05-27
Label2011-04-07
Label2014-09-03
Review2007-01-26
Letter2005-05-27
Letter2014-09-03
Label2009-07-02
Label2010-06-14
Label2014-09-03
Letter2016-10-20
Letter2016-10-20
Label2017-02-22
Label2017-02-22
Pediatric Medical Review1900-01-01
Pediatric CDTL Review1900-01-01
Pediatric Clinical Pharmacology Review1900-01-01
Pediatric Statistical Review1900-01-01

Application Sponsors

NDA 021606ABBVIE

Marketing Status

Prescription001
Prescription002
Discontinued003

Application Products

001CAPSULE;ORAL1MCG1ZEMPLARPARICALCITOL
002CAPSULE;ORAL2MCG1ZEMPLARPARICALCITOL
003CAPSULE;ORAL4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1ZEMPLARPARICALCITOL

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2005-05-26STANDARD
EFFICACY; EfficacySUPPL4AP2009-06-29UNKNOWN
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2007-07-17N/A
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2008-06-18N/A
LABELING; LabelingSUPPL7AP2010-06-11STANDARD
LABELING; LabelingSUPPL9AP2011-04-06UNKNOWN
MANUF (CMC); Manufacturing (CMC)SUPPL10AP2012-06-28STANDARD
LABELING; LabelingSUPPL12AP2014-08-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL13AP2013-10-17STANDARD
LABELING; LabelingSUPPL14AP2014-08-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP2015-08-18STANDARD
EFFICACY; EfficacySUPPL16AP2016-10-18STANDARD
EFFICACY; EfficacySUPPL17AP2016-10-18STANDARD

Submissions Property Types

SUPPL7Null6
SUPPL9Null7
SUPPL10Null0
SUPPL12Null15
SUPPL13Null0
SUPPL14Null15
SUPPL15Null0
SUPPL16Null15
SUPPL17Null6

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

ABBVIE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21606
            [companyName] => ABBVIE
            [docInserts] => ["",""]
            [products] => [{"drugName":"ZEMPLAR","activeIngredients":"PARICALCITOL","strength":"1MCG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"ZEMPLAR","activeIngredients":"PARICALCITOL","strength":"2MCG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"ZEMPLAR","activeIngredients":"PARICALCITOL","strength":"4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"10\/18\/2016","submission":"SUPPL-17","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/021606s016s017lbl.pdf\"}]","notes":""},{"actionDate":"10\/18\/2016","submission":"SUPPL-16","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/021606s016s017lbl.pdf\"}]","notes":""},{"actionDate":"08\/29\/2014","submission":"SUPPL-14","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/021606s012s014lbl.pdf\"}]","notes":""},{"actionDate":"08\/29\/2014","submission":"SUPPL-12","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/021606s012s014lbl.pdf\"}]","notes":""},{"actionDate":"04\/06\/2011","submission":"SUPPL-9","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/021606s009lbl.pdf\"}]","notes":""},{"actionDate":"06\/11\/2010","submission":"SUPPL-7","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/021606s007lbl.pdf\"}]","notes":""},{"actionDate":"06\/29\/2009","submission":"SUPPL-4","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/021606s004lbl.pdf\"}]","notes":""},{"actionDate":"05\/26\/2005","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/021606lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"ZEMPLAR","submission":"PARICALCITOL","actionType":"1MCG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"ZEMPLAR","submission":"PARICALCITOL","actionType":"2MCG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"ZEMPLAR","submission":"PARICALCITOL","actionType":"4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2016-10-18
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.